In 2021, the Australian Thyroid Foundation released analysis to show, well over 1 million Australian are living with an undiagnosed thyroid disorder, including thyroid cancer, lower IQs, lifelong disability, and a causal or possible contributory factor – in the development of other neurological disorders such as ADHD and autism. Some of the challenges for diagnosis and treatment can be addressed by producing material for health care practitioners during patient presentations.
‘Recent statistics show well over 1 million Australians are living with an undiagnosed thyroid disorder, awareness and testing can prevent unwarranted outcomes for mothers and their babies’ says ATF CEO Beverley Garside OAM
Australia has been labelled by the World Health Organisation (WHO) as being iodine deficient, and evidenced in research in 2005-06 by Westmead Hospital and Sydney University (see 1 below)
The World Health Organisation states iodine deficiency during pregnancy and early infancy –the first 1000 days of life when development of the human brain is so critical – is the commonest global cause of preventable intellectual disability (see 2 below)
Thyroid Disorders affect all Australians of all age groups and demographics. Awareness is the key to ensuring the public and healthcare professionals do not overlook a thyroid disorder which could be affecting health and wellbeing.
– 1 in 10 Australians will be affected by some form of thyroid disorder
– 7 of the 10 are women
– Over 1 million Australians are undiagnosed
– 60,000 Australians are diagnosed each year
– Thyroid Cancer is increasing, affecting younger Australians
– Iodine Deficiency & Thyroid Disorders affect pregnancy outcomes for women of childbearing years.
As a Not-For-Profit health charity, The Australian Thyroid Foundation Ltd (ATF) mission is to offer information, education, advocacy and support to members and their families, using services provided by ATF and raise much needed awareness throughout Australia about the consequences of thyroid disease and iodine deficiency and the benefits of achieving good thyroid health.
In recent years ATF has launched campaigns aimed at reaching a number of patient types requiring treatment for the thyroid gland and thyroid hormone production. These have created some level of awareness within the public and health care professionals (HCPs).
The Australian Thyroid Foundation has lodged a Pre-Budget Submission for the Federal Budget 2024-25 to counter increasing misinformation on social media creating dietary deficiencies such as an increasing number of young women, who are planning pregnancy or already pregnant opting for plant based milks such almond, soy or oat milk coffee as an alternative to standard cow’s milk, which is a source of iodine and alternate milks do not include.
Australian Health Journal spoke with endocrinologist, Adj. Prof. Duncan Topliss AM, a Medical Advisory Board Member at The Australian Thyroid Foundation Ltd, about issues raised in the submission.
References
1. Evidence for iodine deficiency in the Australian population was derived from a national study on Australian schoolchildren in 2003-2004 in which the ATF actively participated with a large group of Australian clinical researchers. The outcome was the implementation of the mandatory iodine fortification of all salt used in the baking of bread and bread products in Australia and New Zealand.
2. Multiple studies undertaken on pregnant women have revealed that iodine intake in at least 50% of pregnancies in Australia is deficient, despite the addition of iodised salt to bread, putting the next generation of Australian children at risk of neuro-developmental disorders and lower IQ.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
-
Concerning increases in Non-Alcoholic Fatty Liver Disease and colorectal cancer
Dr Kieran Longley is a Gastroenterologist and Hepatologist committed to providing comprehensive, patient-centred care across a broad spectrum of digestive and liver conditions. He completed his medical degree at the University of Tasmania before undertaking physician training at St Vincent’s Hospital Sydney. Furthering his academic and clinical expertise, he obtained a Master of Science in Internal Medicine from the University of Edinburgh.
